Connect with us

Hi, what are you looking for?

Friday, May 15, 2026
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
TerraCycle secures SEC approval for USD$75M Regulation A crowdfunding raise
TerraCycle secures SEC approval for USD$75M Regulation A crowdfunding raise
An AI display of plastics recycling in action. Image via Dall-E.

Alternative Energy

TerraCycle secures SEC approval for USD$75M Regulation A crowdfunding raise

TerraCycle US plans to use proceeds from the Regulation A raise to pursue acquisitions and scale its recycling infrastructure

TerraCycle US Inc. secured qualification from the U.S. Securities and Exchange Commission this week for a USD$75 million Regulation A offering, positioning the recycling company for another phase of expansion after a successful crowdfunding campaign earlier this year.

The offering follows TerraCycle US’s recently completed Regulation CF raise, which reached the USD$5 million cap in under 60 days. Independent industry analysis also ranked it among the largest Regulation CF raises completed in 2025.

Founder and chief executive Tom Szaky said the company intends to use the new financing to support profitable growth, strategic acquisitions and expanded recycling operations. Additionally, he said investor demand during the Regulation CF campaign reinforced confidence in TerraCycle’s long-term business model.

TerraCycle US plans to use proceeds from the Regulation A raise to pursue acquisitions and scale its recycling infrastructure. Consequently, the company aims to strengthen recurring revenue streams while expanding its market reach.

The company has operated profitably for years while steadily increasing revenue. TerraCycle US reported revenue growth of 75 per cent over the past four years, climbing from USD$24.7 million in 2020 to USD$43.1 million in 2024. Meanwhile, gross profits reached USD$19.3 million last year.

TerraCycle US also pointed to its earlier Regulation A campaign launched in 2018. That raise brought in slightly more than USD$19 million from approximately 6,300 investors. Furthermore, the company said those investors have already received annual dividend payments equal to 17 to 20 per cent of their total invested capital.

Read more: Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation

Read more: Prestigious medtech intelligence firm recognizes Breath Diagnostics for innovation

TerraCycle raises $20m for schools, charities and nonprofits

Since 2018, TerraCycle US has completed three acquisitions aimed at expanding operations and strengthening its competitive position. Additionally, the company said the latest financing will provide a more flexible source of capital than traditional fundraising methods.

Founded in 2001, TerraCycle built its business around recycling materials often excluded from municipal curbside programs. The company processes difficult waste streams including snack wrappers, coffee pods, cosmetics packaging, pet food bags and child car seats.

TerraCycle has also partnered with major consumer brands and retailers such as Procter & Gamble (NYSE: PG), Nestlé (SWX: NESN) and Walmart (NASDAQ: WMT). In addition, the company said its network has recycled more than 8 billion items otherwise destined for landfills or incinerators.

The broader TerraCycle organization has also raised USD$20 million for schools, charities and nonprofit groups worldwide. Furthermore, the company has received more than 200 industry awards, including recognition from TIME Magazine and Fast Company.

Regulation crowdfunding has become increasingly popular among private companies seeking alternatives to venture capital and institutional financing. Consequently, more firms are using Regulation CF and Regulation A offerings to attract retail investors directly.

One recent example is private medical technology company Breath Diagnostics. The Kentucky-based firm launched a Regulation CF campaign last year to support commercialization of its OneBreath lung cancer screening platform. The company sought USD$3 million through the raise while offering shares for USD$3 each. Additionally, Breath Diagnostics promoted the technology as a faster and less invasive alternative to traditional CT-based lung cancer screening.

Private startup marketplace StartEngine has also continued to host Regulation A and Regulation CF raises for technology, healthcare and consumer-focused companies seeking public participation in early-stage financing.

.

Follow Mugglehead on x

Like Mugglehead on Facebook

Follow Joseph Morton on x

joseph@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medical and Pharmaceutical

The robotic system targets nodules in the outer areas of the lung, where traditional procedures can struggle to reach

Medical and Pharmaceutical

Promising, but the findings are derived from a small study

Medical and Pharmaceutical

It works by detecting volatile organic compound associated with the potentially fatal disease

Medical and Pharmaceutical

They have been identified as a high-risk group